MWNA
MRVI icon

Marshall Wace North America’s Maravai LifeSciences MRVI Stock Holding History

Marshall Wace North America’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$16.4M Buy
334,500
+311,886
+1,379% +$15.2M 0.07% 268
2021
Q2 		$944K Sell
22,614
-988,371
-98% -$38.3M ﹤0.01% 1029
2021
Q1 		$36M Buy
1,010,985
+403,431
+66% +$13.4M 0.15% 161
2020
Q4 		$17M Buy
+607,554
New +$16.9M 0.08% 282

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace North America's MRVI Position: Q3 2021 in Review

Marshall Wace North America increased its Maravai LifeSciences (MRVI) stake by 1,379% in Q3 2021, buying an estimated $15.2M and bringing the position to 334,500 shares worth $16.4M. The position accounts for 0.07% of the portfolio, ranked #268.

Marshall Wace North America first reported a position in MRVI in Q4 2020 and has held it in 4 quarters since. The position peaked at $36M in Q1 2021. 228 funds tracked by Wall St. Rank hold MRVI as of Q3 2021.

  • Marshall Wace North America held 334,500 shares of Maravai LifeSciences worth $16.4M as of Q3 2021.
  • Marshall Wace North America bought 311,886 Maravai LifeSciences shares in Q3 2021, an estimated $15.2M.
  • Maravai LifeSciences made up 0.07% of Marshall Wace North America's portfolio in Q3 2021, its #268 holding.
  • Marshall Wace North America first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 4 quarters since.
  • Marshall Wace North America's Maravai LifeSciences position peaked at $36M in Q1 2021.
  • 228 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.